307 related articles for article (PubMed ID: 26476133)
21. Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test.
Tan-No K; Ohshima K; Taira A; Inoue M; Niijima F; Nakagawasai O; Tadano T; Nylander I; Silberring J; Terenius L; Kisara K
Brain Res; 2001 Feb; 891(1-2):274-80. PubMed ID: 11164832
[TBL] [Abstract][Full Text] [Related]
22. Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sato T; Satoh S; Sakurada S; Marinova Z; Yakovleva T; Bakalkin G; Terenius L; Tadano T
Pain; 2005 Feb; 113(3):301-309. PubMed ID: 15661437
[TBL] [Abstract][Full Text] [Related]
23. [Met5]enkephalin and delta2-opioid receptors in the spinal cord are involved in the cold water swimming-induced antinociception in the mouse.
Mizoguchi H; Narita M; Kampine JP; Tseng LF
Life Sci; 1997; 61(7):PL81-6. PubMed ID: 9252252
[TBL] [Abstract][Full Text] [Related]
24. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
25. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
26. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
27. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
[TBL] [Abstract][Full Text] [Related]
28. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
29. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
30. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.
Lewis SS; Hutchinson MR; Rezvani N; Loram LC; Zhang Y; Maier SF; Rice KC; Watkins LR
Neuroscience; 2010 Jan; 165(2):569-83. PubMed ID: 19833175
[TBL] [Abstract][Full Text] [Related]
31. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
[TBL] [Abstract][Full Text] [Related]
32. The cannabinoid 1 receptor antagonist AM251 produces nocifensive behavior via activation of ERK signaling pathway.
Katsuyama S; Mizoguchi H; Komatsu T; Nagaoka K; Sakurada S; Sakurada T
Neuropharmacology; 2010 Nov; 59(6):534-41. PubMed ID: 20654633
[TBL] [Abstract][Full Text] [Related]
33. [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.
Xu JY; Tseng LF
Neuroscience; 1997 Sep; 80(2):579-85. PubMed ID: 9284359
[TBL] [Abstract][Full Text] [Related]
34. Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine.
Liu NJ; von Gizycki H; Gintzler AR
J Pharmacol Exp Ther; 2007 Aug; 322(2):654-60. PubMed ID: 17488879
[TBL] [Abstract][Full Text] [Related]
35. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
36. C-Fos activation in the periaqueductal gray following acute morphine-3β-D-glucuronide or morphine administration.
Arout CA; Caldwell M; McCloskey DP; Kest B
Physiol Behav; 2014 May; 130():28-33. PubMed ID: 24631297
[TBL] [Abstract][Full Text] [Related]
37. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
38. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
39. Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse.
Narita M; Mizoguchi H; Nagase H; Tseng LF
Psychopharmacology (Berl); 1997 Oct; 133(4):347-50. PubMed ID: 9372533
[TBL] [Abstract][Full Text] [Related]
40. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
